Evidence map›Paper›PMID 29507411›Full record

ArticleNature neuroscience2018

Nontoxic, double-deletion-mutant rabies viral vectors for retrograde targeting of projection neurons.

Soumya Chatterjee, Heather A Sullivan, Bryan J MacLennan, Ran Xu, YuanYuan Hou, Thomas K Lavin, Nicholas E Lea, Jacob E Michalski, Kelsey R Babcock, Stephan Dietrich and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 193 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. SpaGene: A Deep Adversarial Framework for Spatial Gene Imputation.Computational and structural biotechnology journal · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Risk reshapes amygdala representation of choice.bioRxiv : the preprint server for biology · 2025
    Article
  12. SpaGene: A Deep Adversarial Framework for Spatial Gene Imputation.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Soumya ChatterjeeAllen Institute for Brain Science, Seattle, WA, USA.
Heather A SullivanMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Bryan J MacLennanAllen Institute for Brain Science, Seattle, WA, USA.
Ran XuMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
YuanYuan HouMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Thomas K LavinMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0269-3325
Nicholas E LeaMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jacob E MichalskiMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Kelsey R BabcockMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Stephan DietrichMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gillian A MatthewsPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Anna BeyelerPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gwendolyn G CalhoonPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gordon GloberPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jennifer D WhitesellAllen Institute for Brain Science, Seattle, WA, USA.
Shenqin YaoAllen Institute for Brain Science, Seattle, WA, USA.
Ali CetinAllen Institute for Brain Science, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-1510-0517
Julie A HarrisAllen Institute for Brain Science, Seattle, WA, USA.
Hongkui ZengAllen Institute for Brain Science, Seattle, WA, USA.
Kay M TyePicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
R Clay ReidAllen Institute for Brain Science, Seattle, WA, USA.
Ian R WickershamMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA. wickersham@mit.edu.ORCID http://orcid.org/0000-0003-0389-5324
McGovern Institute for Brain Research · USAllen Institute for Brain Science · USMassachusetts Institute of Technology · US

Funding

Generation of novel cell type specific mouse genetic toolsU19MH114830 · NIMH · ALLEN INSTITUTE · PI NGAI, JOHN J. · 2017 to 2021
$64.7M
Functional micro-architecture of the visual cortexR01EY010115 · NEI · ROCKEFELLER UNIVERSITY · PI REID, R CLAY · 1993 to 2023
$8.9M
Mouse Cell Type-Specific Brain Mapping in Health and DiseaseR01AG047589 · NIA · ALLEN INSTITUTE · PI HARRIS, JULIE · 2014 to 2018
$3.4M
Neuronal ensembles in the rodent visual cortexR01EY018742 · NEI · HARVARD MEDICAL SCHOOL · PI REID, R CLAY · 2008 to 2015
$3.1M
Novel technologies for nontoxic transsynaptic tracingU01MH106018 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WICKERSHAM, IAN R · 2014 to 2016
$2.5M
NEI NIH HHS R01 EY010115NEI NIH HHS R01 EY018742NIA NIH HHS R01 AG047589NIMH NIH HHS U01 MH106018NIMH NIH HHS U19 MH114830
6 · The paper itself

Abstract

Recombinant rabies viral vectors have proven useful for applications including retrograde targeting of projection neurons and monosynaptic tracing, but their cytotoxicity has limited their use to short-term experiments. Here we introduce a new class of double-deletion-mutant rabies viral vectors that left transduced cells alive and healthy indefinitely. Deletion of the viral polymerase gene abolished cytotoxicity and reduced transgene expression to trace levels but left vectors still able to retrogradely infect projection neurons and express recombinases, allowing downstream expression of other transgene products such as fluorophores and calcium indicators. The morphology of retrogradely targeted cells appeared unperturbed at 1 year postinjection. Whole-cell patch-clamp recordings showed no physiological abnormalities at 8 weeks. Longitudinal two-photon structural and functional imaging in vivo, tracking thousands of individual neurons for up to 4 months, showed that transduced neurons did not die but retained stable visual response properties even at the longest time points imaged.

Indexed as

Action PotentialsAge FactorsAnalysis of VarianceAnimalsCerebral CortexFemaleGenetic VectorsHEK293 CellsHumansLuminescent ProteinsMaleMiceMice, TransgenicNeural PathwaysNeuronsOptogeneticsLuminescent Proteins

Identifiers

PMID29507411
PMCPMC6503322
OpenAlexW2794063115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.